XML 55 R43.htm IDEA: XBRL DOCUMENT v3.6.0.2
Note 1 - Organization and Nature of Business (Details Textual)
2 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jul. 27, 2016
$ / shares
shares
Jun. 27, 2016
$ / shares
shares
Apr. 15, 2016
USD ($)
$ / shares
shares
Mar. 02, 2016
USD ($)
shares
Feb. 13, 2016
Feb. 12, 2016
USD ($)
$ / shares
shares
Apr. 15, 2016
USD ($)
$ / shares
shares
Dec. 31, 2016
shares
Sep. 30, 2016
USD ($)
$ / shares
shares
Sep. 30, 2015
USD ($)
Dec. 31, 2015
$ / shares
shares
Dec. 31, 2014
$ / shares
shares
Jul. 26, 2016
shares
Jun. 26, 2016
$ / shares
shares
Oct. 02, 2015
$ / shares
shares
Oct. 01, 2015
shares
Preferred Stock, Par or Stated Value Per Share | $ / shares $ 0.000001               $ 0.000001   $ 0.000001          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross                 1,974,445   490,000 240,000        
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ / shares                 $ 1.25   $ 1.25 $ 1        
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares                     1          
Common Stock, Par or Stated Value Per Share | $ / shares $ 0.0001 $ 0.0001       $ 0.0001     $ 0.0001   $ 0.0001 $ 0.001   $ 0.000001 $ 0.001  
Number of Wholly-Owned Subsidiaries Split Off         29                      
Stock Issued During Period, Value, New Issues | $                 $ 4,761,797              
Stock Issued During Period, Value, Conversion of Convertible Securities | $                 75,265              
Warrants Issued for Settlement and Conversion of Debt | $                 $ 340,784            
Stock Shares Authorized 120,000,000                              
Common Stock, Shares Authorized 100,000,000 100,000,000             100,000,000   20,000,000 20,000,000   100,000,000,000 20,000,000 10,000,000
Preferred Stock, Shares Authorized 20,000,000 20,000,000             20,000,000   20,000,000     5,000,000,000    
Stock Conversion from Series B Preferred Stock to Common Stock [Member]                                
Convertible Preferred Stock, Shares Issued upon Conversion 1 1                            
Conversion of Stock, Shares Converted                 8,221,837              
Conversion of Stock, Shares Issued                 8,221,837              
Reverse Stock Split [Member]                                
Stockholders' Equity Note, Stock Split, Conversion Ratio   15,463.7183                            
Scenario, Forecast [Member] | Stock Conversion from Series B Preferred Stock to Common Stock [Member]                                
Conversion of Stock, Shares Converted               1,924,163                
Private Placement [Member] | Placement Agent Warrants [Member]                                
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares     $ 1.25       $ 1.25                  
Private Placement [Member] | Commissions [Member]                                
Payments of Stock Issuance Costs | $     $ 159,183                          
Private Placement [Member] | Expense Allowance [Member]                                
Payments of Stock Issuance Costs | $     15,000                          
Private Placement [Member] | Legal and Miscellaneous Fees [Member]                                
Payments of Stock Issuance Costs | $     $ 266,727                          
Momspot LLC [Member]                                
Noncontrolling Interest, Ownership Percentage by Parent           51.00%                    
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners           49.00%                    
Interest Ownership Split Off         51.00%                      
Investors in the Private Offering [Member]                                
Number of Common Stock Held As Converted Basis           2,775,000                    
Debt Principal Conversion to Predecessor Warrants [Member]                                
Debt Conversion, Original Debt, Amount | $           $ 665,000                    
Debt Interest Conversion to Predecessor Warrants [Member]                                
Debt Conversion, Original Debt, Amount | $           35,000                    
Conversion of Outstanding Stockholder Debt [Member] | Chairman and Board Member Garo H. Armen [Member]                                
Stock Issued During Period, Value, Conversion of Convertible Securities | $           350,000                    
Conversion of Outstanding Stockholder Debt [Member] | Predecessor's Stockholder [Member]                                
Stock Issued During Period, Value, Conversion of Convertible Securities | $           $ 150,000                    
Common Stock [Member]                                
Stock Issued During Period, Shares, Reverse Stock Split, Post-split           25,867                    
Stock Issued During Period, Value, New Issues | $                              
Stock Issued During Period, Value, Conversion of Convertible Securities | $                 $ 6              
Stock Issued During Period, Shares, New Issues                   0 0        
Series B Preferred Stock [Member]                                
Stock Issued During Period, Value, Conversion of Convertible Securities | $                              
Proceeds from Issuance of Convertible Preferred Stock | $                 $ 4,283,437            
Potential Percentage of Common Stock Owned by Shareholder 9.99%                              
Conversion of Stock, Shares Eligible for Conversion 10,146,000                              
Preferred Stock, Shares Outstanding                 2,796,929   0   11,018,766      
Conversion of Stock, Shares Eligible for Conversion, Shares to be Issued 10,146,000                              
Conversion of Stock, Remaining Shares to be Converted 872,766                              
Preferred Stock, Shares Authorized                 18,000,000   18,000,000          
Series B Preferred Stock [Member] | Reverse Stock Split [Member]                                
Stockholders' Equity Note, Stock Split, Conversion Ratio 15,463.7183         15,463.7183                    
Series B Preferred Stock [Member] | Predecessor Warrants [Member]                                
Class of Warrant or Right, Number of Securities Called by Warrants or Rights           295,945                    
Warrants Issued for Settlement and Conversion of Debt | $           $ 340,784                    
Series B Preferred Stock [Member] | Private Placement [Member]                                
Class of Warrant or Right, Number of Securities Called by Warrants or Rights           423,291                    
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares           $ 1.25                    
Shares Issued, Price Per Share | $ / shares           $ 1.25                    
Stock Issued During Period, Value, New Issues | $           $ 3,468,750                    
Stock Issued During Period, Shares, New Issues     420,260 913,200   2,775,000 4,108,460                  
Proceeds from Issuance of Convertible Preferred Stock | $     $ 525,325 $ 1,141,500                        
Proceeds from Issuance of Private Placement | $             $ 4,635,575                  
Proceeds From Issuance of Private Placement, Net of Issuance Costs | $             4,283,438                  
Series B Preferred Stock [Member] | Private Placement [Member] | Including Conversion of Principal and Interest [Member]                                
Proceeds from Issuance of Private Placement | $             5,135,575                  
Proceeds From Issuance of Private Placement, Net of Issuance Costs | $             $ 4,783,438                  
Series B Preferred Stock [Member] | Private Placement [Member] | Placement Agent Warrants [Member]                                
Class of Warrant or Right, Number of Securities Called by Warrants or Rights     127,346       127,346                  
Class of Warrant or Right, Value of Securities Called by Warrants or Rights | $     $ 146,641       $ 146,641                  
Series B Preferred Stock [Member] | Common Stock [Member]                                
Stock Issued During Period, Value, Conversion of Convertible Securities | $                 $ 822              
Protagenic Therapeutics Inc [Member]                                
Business Acquisition, Conversion of Stock, Ratio           1                    
Business Combination, Stock Warrant Conversion Ratio           1                    
Stock Issued During Period, Shares, Conversion of Series A Preferred Stock to Series B Preferred Stock           297,468                    
Protagenic Therapeutics Inc [Member] | Placement Agent Warrants [Member]                                
Class of Warrant or Right, Number of Securities Called by Warrants or Rights           127,346                    
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares           $ 1.25                    
Protagenic Therapeutics Inc [Member] | Predecessor Warrants [Member]                                
Class of Warrant or Right, Number of Securities Called by Warrants or Rights           295,945                    
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares           $ 1.25                    
Protagenic Therapeutics Inc [Member] | Private Placement [Member]                                
Class of Warrant or Right, Number of Securities Called by Warrants or Rights           3,403,367                    
Protagenic Therapeutics Inc [Member] | Series B Preferred Stock [Member]                                
Common Shares Exchanged for Preferred Shares           6,612,838                    
Preferred Stock, Par or Stated Value Per Share | $ / shares           $ 0.000001                    
Protagenic Therapeutics Inc [Member] | Series B Preferred Stock [Member] | New Options [Member]                                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross           1,807,744                    
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ / shares           $ 0.87                    
Protagenic Therapeutics Inc [Member] | Series B Preferred Stock [Member] | New Warrants [Member]                                
Class of Warrant or Right, Number of Securities Called by Warrants or Rights           3,403,367                    
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares           $ 1.03                    
Protagenic Therapeutics Inc [Member] | Series B Preferred Stock [Member] | Predecessor Options [Member]                                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross           17,784                    
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ / shares           $ 1.25                    
Class of Warrant or Right, Number of Securities Called by Warrants or Rights           295,945                    
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares           $ 1.25